CN104757424A - Eurycoma longifolia compound granule and preparation method thereof - Google Patents
Eurycoma longifolia compound granule and preparation method thereof Download PDFInfo
- Publication number
- CN104757424A CN104757424A CN201510117895.1A CN201510117895A CN104757424A CN 104757424 A CN104757424 A CN 104757424A CN 201510117895 A CN201510117895 A CN 201510117895A CN 104757424 A CN104757424 A CN 104757424A
- Authority
- CN
- China
- Prior art keywords
- eurycoma longifolia
- tongkat ali
- extract
- mixing
- compound tank
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 240000005739 Eurycoma longifolia Species 0.000 title abstract 11
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 239000008187 granular material Substances 0.000 title abstract 5
- 239000000284 extract Substances 0.000 claims abstract description 24
- 238000002156 mixing Methods 0.000 claims abstract description 23
- 239000002994 raw material Substances 0.000 claims abstract description 20
- 235000014360 Punica granatum Nutrition 0.000 claims abstract description 19
- 150000008442 polyphenolic compounds Chemical class 0.000 claims abstract description 19
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 19
- 235000019202 steviosides Nutrition 0.000 claims abstract description 15
- 238000009835 boiling Methods 0.000 claims abstract description 11
- 238000000605 extraction Methods 0.000 claims abstract description 11
- 238000004806 packaging method and process Methods 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 244000294611 Punica granatum Species 0.000 claims description 17
- 230000015572 biosynthetic process Effects 0.000 claims description 16
- 238000003786 synthesis reaction Methods 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 15
- 239000002245 particle Substances 0.000 claims description 15
- 239000004383 Steviol glycoside Substances 0.000 claims description 13
- 229930182488 steviol glycoside Natural products 0.000 claims description 13
- 235000019411 steviol glycoside Nutrition 0.000 claims description 13
- 150000008144 steviol glycosides Chemical class 0.000 claims description 13
- 238000010792 warming Methods 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 6
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 5
- 229910052782 aluminium Inorganic materials 0.000 claims description 5
- 239000004411 aluminium Substances 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 238000005469 granulation Methods 0.000 claims description 5
- 230000003179 granulation Effects 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 238000012856 packing Methods 0.000 claims description 5
- 238000003860 storage Methods 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 2
- 210000001736 capillary Anatomy 0.000 abstract description 5
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 5
- 210000003734 kidney Anatomy 0.000 abstract description 4
- 206010020772 Hypertension Diseases 0.000 abstract description 3
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 abstract description 3
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 abstract description 3
- 210000001367 artery Anatomy 0.000 abstract description 3
- 210000004204 blood vessel Anatomy 0.000 abstract description 3
- 230000037394 skin elasticity Effects 0.000 abstract description 3
- 229940116269 uric acid Drugs 0.000 abstract description 3
- 210000003462 vein Anatomy 0.000 abstract description 3
- 241000219991 Lythraceae Species 0.000 abstract 2
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 abstract 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 238000009924 canning Methods 0.000 abstract 1
- 229940013618 stevioside Drugs 0.000 abstract 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 5
- 238000012423 maintenance Methods 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000000116 mitigating effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 208000025978 Athletic injury Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000002456 anti-arthritic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 208000001297 phlebitis Diseases 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses an eurycoma longifolia compound granule and a preparation method thereof. The eurycoma longifolia compound granule contains the following raw materials (in weight percentage): pure malt, eurycoma longifolia, stevioside and pomegranate polyphenols. The preparation method of the eurycoma longifolia compound granule consists of the specific steps as follows: treating and blending the raw materials, mixing, canning, packaging and storing. When mixing the raw materials, the roots and stems of the eurycoma longifolia are crushed and canned, pure water with 12-14 times of eurycoma longifolia is added, the eurycoma longifolia are boiled and extracted for three times, the extracts are filtered using a plate and frame filter in 2.5-3.5 hours after each extraction, and the three extracts are blended after the completion of the three boiling and extracting to obtain the eurycoma longifolia extract. The eurycoma longifolia compound granule has simple preparation method, is convenient to eat, can effectively merge the active substances in the eurycoma longifolia and pomegranate polyphenols together, can reduce uric acid by repairing kidney and soften blood vessels, has certain degree of alleviation function on diabetes and hypertension, helps improve joint and skin elasticity, and strengthens arteries, veins and capillaries.
Description
Technical field
The present invention relates to health products manufacture technology field, specifically a kind of Tongkat Ali synthesis particle and preparation method thereof.
Background technology
Tongkat Ali is the one very valuable ingredients of traditional Chinese medicine, and its effect mainly plays maintenance and maintenance effect for kidney, has good curative effect to gout, arthritis, rheumatism; Punica granatum L. polyphenol extract is a class powerful antioxidant, and it is reported to some extent to inflammation effect of Antiarthritic and athletic injury, eye disease as
dRPalso can benefit from it with visual impairment, capillary vigor can be promoted and strengthen capillary wall, improve skin smooth and elasticity, alleviate DRP and improve eyesight, alleviate varication, help improve cerebral function and antagonism arthritic inflammation less trouble phlebitis risk;
Pure Fructus Hordei Germinatus has promote qi circulation digestion promoting, spleen benefiting and stimulating the appetite and delaactation dissipate-swelling; High-purity steviosides has no effect to blood sugar level, and it can not produce any carbohydrate or glycemic load, and diabetic therefore can be helped to regulate blood sugar and insulin level, and it is safe that steviol glycoside is generally acknowledged diabetic.
But Tongkat Ali and Punica granatum L. polyphenol are edible and inconvenient, therefore need badly and develop a kind of synthesis health products that can merge Tongkat Ali and Punica granatum L. polyphenol drug effect.
Summary of the invention
The object of the present invention is to provide and a kind ofly can make Tongkat Ali synthesis particle of simple, instant and preparation method thereof, to solve the problem proposed in above-mentioned background technology.
For achieving the above object, the invention provides following technical scheme:
A kind of Tongkat Ali synthesis particle, comprises according to the raw material of percentage by weight: pure Fructus Hordei Germinatus 64-70%, Tongkat Ali 12-14%, steviol glycoside 8-10%, Punica granatum L. polyphenol 10-12%.
As the present invention's further scheme: described Tongkat Ali synthesis particle, comprises according to the raw material of percentage by weight: pure Fructus Hordei Germinatus 67%, Tongkat Ali 13%, steviol glycoside 9%, Punica granatum L. polyphenol 11%.
The preparation method of described Tongkat Ali synthesis particle, concrete steps are as follows:
(1) Feedstock treating: take each raw material according to percentage by weight, conscientiously checks each raw material variety, weight and outward appearance;
(2) prepare burden: the rhizome of Tongkat Ali is pulverized and tinning, add Tongkat Ali 12-14 pure water doubly, three boilings are divided to extract, after each extraction 2.5-3.5h, extract is filtered through plate filter, after three boiling extractions complete, the extract merging of extracting three times obtains Tongkat Ali extract;
(3) mix: steviol glycoside and above-mentioned Tongkat Ali extract are put into material-compound tank, add the pure water that in material-compound tank, liquid 10-15% measures, be incubated 12-14h after being warming up to 78-82 DEG C, then process is vacuumized to material-compound tank, until bubble-free in material-compound tank;
(4) liquid 70-90 object mesh screen in material-compound tank is slowly put into medicinal liquor barrel after filtering and leave standstill 5.5-6.5h;
(5) tank processed: inserted by the liquid in medicinal liquor barrel in retort and the mixing of pure Fructus Hordei Germinatus, keep 125-130min, then slowly cool to 58-62 DEG C, pour Punica granatum L. polyphenol into after being warming up to 85-87 DEG C, continues mixing 30-40min and obtains mixing massecuite;
(6) packaging warehouse-in: above-mentioned mixing massecuite is poured in sugar manufacturing machinery, puts in storage after cool drying, granulation, the thin packaging of aluminium and external packing.
Compared with prior art, the invention has the beneficial effects as follows:
The present invention makes simply, instant, effectively the active principle of Tongkat Ali and Punica granatum L. polyphenol can be merged, can by reducing uric acid to the maintenance of kidney, softening blood vessel, mitigation is to a certain degree had to diabetes and hypertension, contribute to improving joint elastic force and skin elasticity, strengthening artery, vein and capillary.
Accompanying drawing explanation
Fig. 1 is preparation method's flow chart of the present invention.
Detailed description of the invention
Be described in more detail below in conjunction with the technical scheme of detailed description of the invention to this patent.
Embodiment 1
Refer to Fig. 1, in the present embodiment, a kind of Tongkat Ali synthesis particle, comprises according to the raw material of percentage by weight: pure Fructus Hordei Germinatus 70%, Tongkat Ali 12%, steviol glycoside 8%, Punica granatum L. polyphenol 10%.
The preparation method of described Tongkat Ali synthesis particle, concrete steps are as follows:
(1) Feedstock treating: take each raw material according to percentage by weight, conscientiously checks each raw material variety, weight and outward appearance;
(2) prepare burden: the rhizome of Tongkat Ali is pulverized and tinning, add the pure water of Tongkat Ali 12 times, three boilings are divided to extract, after each extraction 2.5h, extract is filtered through plate filter, after three boiling extractions complete, the extract merging of extracting three times obtains Tongkat Ali extract;
(3) mix: steviol glycoside and above-mentioned Tongkat Ali extract are put into material-compound tank, adds the pure water of liquid 10% amount in material-compound tank, be incubated 12h after being warming up to 78 DEG C, then process is vacuumized to material-compound tank, until bubble-free in material-compound tank;
(4) slowly put into medicinal liquor barrel after being filtered with 70 object mesh screens by liquid in material-compound tank and leave standstill 5.5h;
(5) tank processed: inserted by the liquid in medicinal liquor barrel in retort and the mixing of pure Fructus Hordei Germinatus, keep 125min, then slowly cool to 58 DEG C, pour Punica granatum L. polyphenol into after being warming up to 85 DEG C, continues mixing 30min and obtains mixing massecuite;
(6) packaging warehouse-in: above-mentioned mixing massecuite is poured in sugar manufacturing machinery, puts in storage after cool drying, granulation, the thin packaging of aluminium and external packing.
Embodiment 2
Refer to Fig. 1, in the present embodiment, a kind of Tongkat Ali synthesis particle, comprises according to the raw material of percentage by weight: pure Fructus Hordei Germinatus 67%, Tongkat Ali 13%, steviol glycoside 9%, Punica granatum L. polyphenol 11%.
The preparation method of described Tongkat Ali synthesis particle, concrete steps are as follows:
(1) Feedstock treating: take each raw material according to percentage by weight, conscientiously checks each raw material variety, weight and outward appearance;
(2) prepare burden: the rhizome of Tongkat Ali is pulverized and tinning, add the pure water of Tongkat Ali 13 times, three boilings are divided to extract, after each extraction 3h, extract is filtered through plate filter, after three boiling extractions complete, the extract merging of extracting three times obtains Tongkat Ali extract;
(3) mix: steviol glycoside and above-mentioned Tongkat Ali extract are put into material-compound tank, adds the pure water of liquid 13% amount in material-compound tank, be incubated 13h after being warming up to 80 DEG C, then process is vacuumized to material-compound tank, until bubble-free in material-compound tank;
(4) slowly put into medicinal liquor barrel after being filtered with 80 object mesh screens by liquid in material-compound tank and leave standstill 6h;
(5) tank processed: inserted by the liquid in medicinal liquor barrel in retort and the mixing of pure Fructus Hordei Germinatus, keep 128min, then slowly cool to 60 DEG C, pour Punica granatum L. polyphenol into after being warming up to 86 DEG C, continues mixing 35min and obtains mixing massecuite;
(6) packaging warehouse-in: above-mentioned mixing massecuite is poured in sugar manufacturing machinery, puts in storage after cool drying, granulation, the thin packaging of aluminium and external packing.
Embodiment 3
Refer to Fig. 1, in the present embodiment, a kind of Tongkat Ali synthesis particle, comprises according to the raw material of percentage by weight: pure Fructus Hordei Germinatus 64%, Tongkat Ali 14%, steviol glycoside 10%, Punica granatum L. polyphenol 12%.
The preparation method of described Tongkat Ali synthesis particle, concrete steps are as follows:
(1) Feedstock treating: take each raw material according to percentage by weight, conscientiously checks each raw material variety, weight and outward appearance;
(2) prepare burden: the rhizome of Tongkat Ali is pulverized and tinning, add the pure water of Tongkat Ali 14 times, three boilings are divided to extract, after each extraction 3.5h, extract is filtered through plate filter, after three boiling extractions complete, the extract merging of extracting three times obtains Tongkat Ali extract;
(3) mix: steviol glycoside and above-mentioned Tongkat Ali extract are put into material-compound tank, adds the pure water of liquid 15% amount in material-compound tank, be incubated 14h after being warming up to 82 DEG C, then process is vacuumized to material-compound tank, until bubble-free in material-compound tank;
(4) slowly put into medicinal liquor barrel after being filtered with 90 object mesh screens by liquid in material-compound tank and leave standstill 6.5h;
(5) tank processed: inserted by the liquid in medicinal liquor barrel in retort and the mixing of pure Fructus Hordei Germinatus, keep 130min, then slowly cool to 62 DEG C, pour Punica granatum L. polyphenol into after being warming up to 87 DEG C, continues mixing 40min and obtains mixing massecuite;
(6) packaging warehouse-in: above-mentioned mixing massecuite is poured in sugar manufacturing machinery, puts in storage after cool drying, granulation, the thin packaging of aluminium and external packing.
The present invention makes simply, instant, effectively the active principle of Tongkat Ali and Punica granatum L. polyphenol can be merged, can by reducing uric acid to the maintenance of kidney, softening blood vessel, mitigation is to a certain degree had to diabetes and hypertension, contribute to improving joint elastic force and skin elasticity, strengthening artery, vein and capillary.
Above the better embodiment of this patent is explained in detail, but this patent is not limited to above-mentioned embodiment, in the ken that one skilled in the relevant art possesses, various change can also be made under the prerequisite not departing from this patent aim.
Claims (3)
1. a Tongkat Ali synthesis particle, is characterized in that, comprise according to the raw material of percentage by weight: pure Fructus Hordei Germinatus 64-70%, Tongkat Ali 12-14%, steviol glycoside 8-10%, Punica granatum L. polyphenol 10-12%.
2. Tongkat Ali synthesis particle according to claim 1, is characterized in that, comprise according to the raw material of percentage by weight: pure Fructus Hordei Germinatus 67%, Tongkat Ali 13%, steviol glycoside 9%, Punica granatum L. polyphenol 11%.
3. a preparation method for the Tongkat Ali synthesis particle as described in as arbitrary in claim 1-2, it is characterized in that, concrete steps are as follows:
(1) Feedstock treating: take each raw material according to percentage by weight, conscientiously checks each raw material variety, weight and outward appearance;
(2) prepare burden: the rhizome of Tongkat Ali is pulverized and tinning, add Tongkat Ali 12-14 pure water doubly, three boilings are divided to extract, after each extraction 2.5-3.5h, extract is filtered through plate filter, after three boiling extractions complete, the extract merging of extracting three times obtains Tongkat Ali extract;
(3) mix: steviol glycoside and above-mentioned Tongkat Ali extract are put into material-compound tank, add the pure water that in material-compound tank, liquid 10-15% measures, be incubated 12-14h after being warming up to 78-82 DEG C, then process is vacuumized to material-compound tank, until bubble-free in material-compound tank;
(4) liquid 70-90 object mesh screen in material-compound tank is slowly put into medicinal liquor barrel after filtering and leave standstill 5.5-6.5h;
(5) tank processed: inserted by the liquid in medicinal liquor barrel in retort and the mixing of pure Fructus Hordei Germinatus, keep 125-130min, then slowly cool to 58-62 DEG C, pour Punica granatum L. polyphenol into after being warming up to 85-87 DEG C, continues mixing 30-40min and obtains mixing massecuite;
(6) packaging warehouse-in: above-mentioned mixing massecuite is poured in sugar manufacturing machinery, puts in storage after cool drying, granulation, the thin packaging of aluminium and external packing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510117895.1A CN104757424A (en) | 2015-03-18 | 2015-03-18 | Eurycoma longifolia compound granule and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510117895.1A CN104757424A (en) | 2015-03-18 | 2015-03-18 | Eurycoma longifolia compound granule and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104757424A true CN104757424A (en) | 2015-07-08 |
Family
ID=53639802
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510117895.1A Pending CN104757424A (en) | 2015-03-18 | 2015-03-18 | Eurycoma longifolia compound granule and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104757424A (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101829182A (en) * | 2010-03-04 | 2010-09-15 | 杨勇 | Medicament for treating prostatic diseases |
| CN101940620A (en) * | 2010-09-14 | 2011-01-12 | 广州市和藤医药研究开发有限公司 | Medicinal composition for treating diabetes mellitus and application thereof |
| CN102911846A (en) * | 2012-09-11 | 2013-02-06 | 严政 | Eurycoma longifolia synthetic health-care drinks |
| CN102948524A (en) * | 2011-08-18 | 2013-03-06 | 顾立峰 | Processing method of eurycoma longifolia |
| CN103564125A (en) * | 2013-10-18 | 2014-02-12 | 毛清奎 | Ginseng candy and production method thereof |
| CN104257704A (en) * | 2014-09-17 | 2015-01-07 | 张卉 | Novel application of eurycoma longifolia extracts |
-
2015
- 2015-03-18 CN CN201510117895.1A patent/CN104757424A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101829182A (en) * | 2010-03-04 | 2010-09-15 | 杨勇 | Medicament for treating prostatic diseases |
| CN101940620A (en) * | 2010-09-14 | 2011-01-12 | 广州市和藤医药研究开发有限公司 | Medicinal composition for treating diabetes mellitus and application thereof |
| CN102948524A (en) * | 2011-08-18 | 2013-03-06 | 顾立峰 | Processing method of eurycoma longifolia |
| CN102911846A (en) * | 2012-09-11 | 2013-02-06 | 严政 | Eurycoma longifolia synthetic health-care drinks |
| CN103564125A (en) * | 2013-10-18 | 2014-02-12 | 毛清奎 | Ginseng candy and production method thereof |
| CN104257704A (en) * | 2014-09-17 | 2015-01-07 | 张卉 | Novel application of eurycoma longifolia extracts |
Non-Patent Citations (2)
| Title |
|---|
| BEAUTY4: "《18种超好玩又便宜的出境旅游点》", 31 January 2008, 中国旅游出版社 * |
| 侯乐峰等: "《中国石榴产业高层论坛论文集》", 30 September 2013, 中国林业出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104287013B (en) | A kind of reducing blood lipid function of blood sugar reduction sexual health vinegar beverage and production technology thereof | |
| CN104171774B (en) | A kind of enzymolysis local flavor gold Fructus Citri grandis cream and preparation method thereof | |
| CN102178756A (en) | Oral liquid for treating high altitude disease (HAD) and preparation method thereof | |
| CN104560570A (en) | Maca juice liquor and preparation method thereof | |
| CN102835508B (en) | Lyceum chinense-green tea beverage | |
| CN101649284B (en) | Acanthopanax sessiliflorus fruit wine and brewing method thereof | |
| CN104522785A (en) | Maca drink and preparing method thereof | |
| CN114947024A (en) | Grapefruit composite fruit and vegetable juice beverage formula and preparation method thereof | |
| CN103584095B (en) | Treat hypertensive health beverages and preparation method thereof | |
| CN104207286B (en) | One protects liver herbal health care vinegar beverage | |
| CN103445249A (en) | Northeast wild kiwi beverage and preparation method thereof | |
| CN105535259A (en) | Fructus rhodomyrti liquor and preparation method thereof | |
| CN104757424A (en) | Eurycoma longifolia compound granule and preparation method thereof | |
| CN102978091B (en) | Technology for preparing health wine from hippophae rhamnoides and gynostemma pentaphylla | |
| CN105533725A (en) | Maca particles and preparation method thereof | |
| CN105166917A (en) | Lemon ferment nutrition solution and preparation method thereof | |
| CN100488546C (en) | Medicine for reducing blood sugar, blood pressure and improving microcirculation and immunity, and its preparation method | |
| CN104720043A (en) | Plant health beverage and preparation method thereof | |
| CN109966459A (en) | A traditional Chinese medicine preparation with functions of relieving neck fatigue and improving cervical vertebra hyperplasia and preparation method thereof | |
| CN104207285A (en) | Functional health vinegar drink capable of benefiting spleen and invigorating stomach and production process thereof | |
| CN105533095A (en) | Solanum nigrum particles and preparation method thereof | |
| CN109288955A (en) | A kind of antihypertensive drug wine | |
| CN102220216B (en) | Acanthopanax sessiliflorus white spirit and brewing method thereof | |
| CN105838552A (en) | Technology for manufacturing curative wine from sea buckthorn fruits and ginseng | |
| CN105341251A (en) | Preparation method of long term-preservation blood fat reducing and blood pressure reducing tea |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150708 |